The therapeutic effects of ONO-1301 against liver damage, fibrosis, and occurrence of liver tumors were evaluated using melanocortin 4 receptor-deficient (Mc4r-KO) NASH model mice. The gene discussed is MC4R; the disease is metabolic dysfunction-associated steatohepatitis.